Attend our Seminar : 

Thursday, June 20 | 12:30pm–1:00pm Beacon Hill Hall, Harbor Level

Christopher Bunker, PhD, MBA, Senior Director, Business Development,

Advanced Cell Diagnostics, Inc., a Bio-Techne brand will be speaking on Biomarker Development with RNAscope™ in situ Hybridization Assay PlatformC8B: Small Molecules for Immuno-Oncology Therapeutic Small Molecules for Immuno-Oncology Therapeutics  TARGETING IMMUNO-METABOLISM FOR CANCER

For more information visit ACD @ acdbio.com/science/applications/research-areas/neuroscience

Visit our CAR-T Poster :

Tuesday, June 18-20 | Commonwealth Hall

#103 Preclinical CAR-T Cell Target Safety, Biodistribution, and Tumor Infiltration Analysis Using In Situ Hybridization Technology

Presented by Christopher Bunker

Come see us at ACD Booth # 216